Indaptus Therapeutics Inc Sustainability Reports

Indaptus Therapeutics, Inc. is a clinical-stage biotechnology company. It engages in the development of a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy.

Sector: Manufacturing

Country: United States

Exchange: Nasdaq

No reports are currently available in our catalogue.